Paneni F, Beckman JA, Creager MA, Cosentino F. Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part I. Eur Heart J. 2013;34:2436–43. https://doi.org/10.1093/eurheartj/eht149.
Article
CAS
PubMed
PubMed Central
Google Scholar
Rask-Madsen C, King GL. Vascular complications of diabetes: mechanisms of injury and protective factors. Cell Metab. 2013;17:20–33. https://doi.org/10.1016/j.cmet.2012.11.012.
Article
CAS
PubMed
PubMed Central
Google Scholar
Elias MF, Crichton GE, Dearborn PJ, Robbins MA, Abhayaratna WP. Associations between type 2 diabetes mellitus and arterial stiffness: a prospective analysis based on the maine-syracuse study. Pulse. 2017;5:88–98. https://doi.org/10.1159/000479560.
Article
PubMed
PubMed Central
Google Scholar
Loehr LR, Meyer ML, Poon AK, Selvin E, Palta P, Tanaka H, et al. Prediabetes and diabetes are associated with arterial stiffness in older adults: the ARIC study. Am J Hypertens. 2016;29:1038–45.
Article
Google Scholar
Zieman SJ, Melenovsky V, Kass DA. Mechanisms, pathophysiology, and therapy of arterial stiffness. Arter Thromb Vasc Biol. 2005;25:932–43.
Article
CAS
Google Scholar
Mattace-Raso FUS, van der Cammen TJM, Hofman A, Van PNM, Bos ML, Schalekamp MADH, et al. Arterial stiffness and risk of coronary heart disease the rotterdam study. Circulation. 2006;113:657–63.
Article
Google Scholar
Kim JM, Kim SS, Kim IJ, Kim JH, Kim BH, Kim MK, et al. Arterial stiffness is an independent predictor for risk of mortality in patients with type 2 diabetes mellitus: the REBOUND study. Cardiovasc Diabetol. 2020;19:143. https://doi.org/10.1186/s12933-020-01120-6.
Article
CAS
PubMed
PubMed Central
Google Scholar
Yiu K-H, Zhao C-T, Chen Y, Siu C-W, Chan Y-H, Lau K-K, et al. Association of subclinical myocardial injury with arterial stiffness in patients with type 2 diabetes mellitus. Cardiovasc Diabetol. 2013;12:94. https://doi.org/10.1186/1475-2840-12-94.
Article
CAS
PubMed
PubMed Central
Google Scholar
Greene SJ, Harinstein ME, Vaduganathan M, Subačius H, Konstam MA, Zannad F, et al. Prognostic value of monocyte count in patients hospitalized for heart failure with reduced ejection fraction (from the EVEREST Trial). Am J Cardiol. 2012;110:1657–62.
Article
Google Scholar
Hu J, Xi D, Zhao J, Luo T, Liu J, Lu H, et al. High-density Lipoprotein and inflammation and its significance to atherosclerosis. Am J Med Sci. 2016;352:408–15.
Article
Google Scholar
Lüscher TF, Landmesser U, Von EA, Fogelman AM. High-density lipoprotein: vascular protective effects, dysfunction, and potential as therapeutic target. Circ Res. 2014;114:171–82.
Article
Google Scholar
Gembillo G, Siligato R, Cernaro V, Satta E, Conti G, Salvo A, et al. Monocyte to HDL ratio: a novel marker of resistant hypertension in CKD patients. Int Urol Nephrol. 2021. https://doi.org/10.1007/s11255-021-02904-9.
Article
PubMed
Google Scholar
Karatas A, Turkmen E, Erdem E, Dugeroglu H, Kaya Y. Monocyte to high-density lipoprotein cholesterol ratio in patients with diabetes mellitus and diabetic nephropathy. Biomark Med. 2018;12:953–9. https://doi.org/10.2217/bmm-2018-0048.
Article
CAS
PubMed
Google Scholar
Cannon CP, Brindis RG, Chaitman BR, Cohen DJ, Cross JT, Drozda JP, et al. 2013 ACCF/AHA Key data elements and definitions for measuring the clinical management and outcomes of patients with acute coronary syndromes and coronary artery disease: a report of the American college of cardiology foundation/American Heart Association. Circulation. 2013;127:1052–89.
Article
Google Scholar
Stone NJ, Jennifer GR, Lichtenstein AH, Merz CNB, Blum CB, Eckel RH, et al. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults. Circulation. 2014;129(25_suppl_2):S1-45. https://doi.org/10.1161/01.cir.0000437738.63853.7a.
Article
PubMed
Google Scholar
Chung S-L, Yang C-C, Chen C-C, Hsu Y-C, Lei M-H. Coronary artery calcium score compared with cardio-ankle vascular index in the prediction of cardiovascular events in asymptomatic patients with type 2 diabetes. J Atheroscler Thromb. 2015;22:1255–65.
Article
CAS
Google Scholar
Asmar R. Principles and usefulness of the cardio-ankle vascular index (CAVI): a new global arterial stiffness index. Eur Hear J Suppl. 2017;19(Supplement B):B4-10.
Article
Google Scholar
Kubota Y, Maebuchi D, Takei M, Inui Y, Sudo Y, Ikegami Y, et al. Cardio-ankle vascular index is a predictor of cardiovascular events. Artery Res. 2011;5:91–6. https://doi.org/10.1016/j.artres.2011.03.005.
Article
Google Scholar
Furuya F, Motosugi A, Haraguchi K, Hanai S, Ishii T, Yamaguchi Y, et al. Association between the cardio-ankle vascular index and diabetes mellitus-related peripheral arterial disease in chronic hemodialysis patients. Blood Purif. 2019;47(suppl 2):1–6.
Google Scholar
Hayashi K, Yamamoto T, Takahara A, Shirai K. Clinical assessment ofarterial stiffness with cardio-ankle vascular index: theory and applications. J Hypertens. 2015;33:1742–57.
Article
CAS
Google Scholar
Takaki A, Ogawa H, Wakeyama T, Iwami T, Kimura M, Hadano Y, et al. Cardio-ankle vascular index is a new noninvasive parameter of arterial stiffness. Circ J. 2007;71:1710–4.
Article
CAS
Google Scholar
Yayla KG, Canpolat U, Yayla Ç, Akboga MK, Akyel A, Akdi A, et al. A novel marker of impaired aortic elasticity in never treated hypertensive patients: monocyte/high-density lipoprotein cholesterol ratio. Acta Cardiol Sin. 2017;33:41–9.
PubMed
PubMed Central
Google Scholar
Chirinos JA, Segers P, Hughes T, Townsend R. Large-artery stiffness in health and disease: JACC state-of-the-art review. J Am College Cardiol. 2019;74:1237–63.
Article
Google Scholar
Chapman CML, Beilby JP, McQuillan BM, Thompson PL, Hung J. Monocyte count, but not c-reactive protein or interleukin-6, is an independent risk marker for subclinical carotid atherosclerosis. Stroke. 2004;35:1619–24. https://doi.org/10.1161/01.STR.0000130857.19423.ad.
Article
CAS
PubMed
Google Scholar
Devaraj S, Jialal I. Low-density lipoprotein postsecretory modification, monocyte function, and circulating adhesion molecules in type 2 diabetic patients with and without macrovascular complications. Circulation. 2000;102:191–6. https://doi.org/10.1161/01.CIR.102.2.191.
Article
CAS
PubMed
Google Scholar
Cipolletta C, Ryan KE, Hanna EV, Trimble ER. Activation of peripheral blood CD14+ monocytes occurs in diabetes. Diabetes. 2005;54:2779–86.
Article
CAS
Google Scholar
Nikiforov NG, Galstyan KO, Nedosugova LV, Elizova NV, Kolmychkova KI, Ivanova EA. Proinflammatory monocyte polarization in type 2 diabetes mellitus and coronary heart disease. Vessel Plus. 2017;1:192–5.
CAS
Google Scholar
Prenner SB, Chirinos JA. Arterial stiffness in diabetes mellitus. Atherosclerosis. 2015;238:370–9. https://doi.org/10.1016/j.atherosclerosis.2014.12.023.
Article
CAS
PubMed
Google Scholar
Chiesa ST, Charakida M. High-density lipoprotein function and dysfunction in health and disease. Cardiovasc Drugs Ther. 2019;33:207–19. https://doi.org/10.1007/s10557-018-06846-w.
Article
CAS
PubMed
PubMed Central
Google Scholar
Chen JW, Li C, Liu ZH, Shen Y, Ding FH, Shu XY, et al. The role of monocyte to high-density lipoprotein cholesterol ratio in prediction of carotid intima-media thickness in patients with type 2 diabetes. Front Endocrinol (Lausanne). 2019;10:1–11.
Article
Google Scholar
Uslu AU, Sekin Y, Tarhan G, Canakcı N, Gunduz M, Karagulle M. Evaluation of monocyte to high-density lipoprotein cholesterol ratio in the presence and severity of metabolic syndrome. Clin Appl Thromb. 2018;24:828–33.
Article
CAS
Google Scholar
Vahit D, Akboga MK, Samet Y, Hüseyin E. Assessment of monocyte to high density lipoprotein cholesterol ratio and lymphocyte-to-monocyte ratio in patients with metabolic syndrome. Biomark Med. 2017;11:535–40. https://doi.org/10.2217/bmm-2016-0380.
Article
CAS
PubMed
Google Scholar
Min D, Brooks B, Wong J, Salomon R, Bao W, Harrisberg B, et al. Alterations in monocyte CD16 in association with diabetes complications. Mediators Inflamm. 2012;2012: 649083. https://doi.org/10.1155/2012/649083.
Article
CAS
PubMed
PubMed Central
Google Scholar
Gordon SM, Davidson WS, Urbina EM, Dolan LM, Heink A, Zang H, et al. The effects of type 2 diabetes on lipoprotein composition and arterial stiffness in male youth. Diabetes. 2013;62:2958–67.
Article
CAS
Google Scholar
Mooradian AD. Dyslipidemia in type 2 diabetes mellitus. Nat Clin Pract Endocrinol Metab. 2009;5:150–9.
CAS
PubMed
Google Scholar
Liu Y, Lai X, Guo W, Ma L, Li W, Fang Q, et al. Total white blood cell count mediated the association between increased arterial stiffness and risk of type 2 diabetes mellitus in chinese adults. Arterioscler Thromb Vasc Biol. 2020;40:1009–15. https://doi.org/10.1161/ATVBAHA.119.313880.
Article
CAS
PubMed
Google Scholar
Wang H, Liu J, Zhao H, Zhao X, Li L, Shi H, et al. Relationship between cardio-ankle vascular index and plasma lipids in hypertension subjects. J Hum Hypertens. 2015;29:105–8.
Article
Google Scholar
Gottsäter M, Länne T, Nilsson PM. Predictive markers of abdominal aortic stiffness measured by echo-tracking in subjects with varying insulin sensitivity. J Hum Hypertens. 2014;28:456–60.
Article
Google Scholar
Wang H, Shi W, Yi X, Zhou Y, Wang Z, Sun Y. Assessing the performance of monocyte to high-density lipoprotein ratio for predicting ischemic stroke: insights from a population- based Chinese cohort. Lipids Health Disease. 2019;18:1–11.
Article
Google Scholar
Çakar M, Balta Ş, Şarlak H, Akhan M, Demirkol S, Karaman M, et al. Arterial stiffness and endothelial inflammation in prediabetes and newly diagnosed diabetes patients. Arch Endocrinol Metab. 2015;59:407–13.
Article
Google Scholar
Mahmud A, Feely J. Arterial stiffness is related to systemic inflammation in essential hypertension. Hypertension. 2005;46:1118–22.
Article
CAS
Google Scholar
Yasmin MECM, Wallace S, Mackenzie IS, Cockcroft JR, Wilkinson IB. C-reactive protein is associated with arterial stiffness in apparently healthy individuals. Arterioscler Thromb Vasc Biol. 2004;24:969–74. https://doi.org/10.1161/01.ATV.zhq0504.0173.
Canpolat U, Ҫetin EH, Cetin S, Aydin S, Akboga MK, Yayla C, et al. Association of monocyte-to-HDL cholesterol ratio with slow coronary flow association of monocyte-to-HDL cholesterol ratio with slow coronary flow is linked to systemic inflammation. Clin Appl Thromb. 2015;22:1–7.
Cetin MS, Hande E, Cetin O. Monocyte to HDL cholesterol ratio predicts coronary artery disease severity and future major cardiovascular adverse events in acute coronary syndrome. Heart Lung Circ. 2016;25:1077–86. https://doi.org/10.1016/j.hlc.2016.02.023.
Article
PubMed
Google Scholar
Villanueva DLE, Tiongson MD, Ramos JD, Llanes EJ. Monocyte to high-density lipoprotein ratio (MHR) as a predictor of mortality and major adverse cardiovascular events (MACE) among ST elevation myocardial infarction (STEMI) patients undergoing primary percutaneous coronary intervention: a meta-analysis. Lipids Health Dis. 2020;19:55. https://doi.org/10.1186/s12944-020-01242-6.
Article
PubMed
PubMed Central
Google Scholar
Ya G, Qiu Z, Tianrong P. Relation of monocyte/high-density lipoprotein cholesterol ratio with coronary artery disease in type 2 diabetes mellitus. Clin Lab. 2018;64:901–6.
Article
CAS
Google Scholar